标题
Challenges in Chagas Disease Drug Development
作者
关键词
-
出版物
MOLECULES
Volume 25, Issue 12, Pages 2799
出版商
MDPI AG
发表日期
2020-06-19
DOI
10.3390/molecules25122799
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection
- (2020) Gurdip Singh Mann et al. PLoS Neglected Tropical Diseases
- High-Throughput Screening of the ReFRAME Library Identifies Potential Drug Repurposing Candidates for Trypanosoma cruzi
- (2020) Jean A. Bernatchez et al. Microorganisms
- Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America
- (2019) Julio Alonso-Padilla et al. Expert Review of Anti-Infective Therapy
- Identification of novel Trypanosoma cruzi proteasome inhibitors using a luminescence-based high-throughput screening assay.
- (2019) Filip Zmuda et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis
- (2019) Eric Pelfrene et al. PLoS Neglected Tropical Diseases
- Trypanosoma cruzi Phosphomannomutase and Guanosine Diphosphate-Mannose Pyrophosphorylase Ligandability Assessment
- (2019) Filip Zmuda et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An evaluation of benznidazole as a Chagas disease therapeutic
- (2019) Ivo S. Caldas et al. EXPERT OPINION ON PHARMACOTHERAPY
- Organometallic Gold(III) Complex [Au(Hdamp)(L14)]+ (L1 = SNS-Donating Thiosemicarbazone) as a Candidate to New Formulations against Chagas Disease
- (2019) Carla Duque Lopes et al. ACS Infectious Diseases
- Chagas Disease in the United States: a Public Health Approach
- (2019) Caryn Bern et al. CLINICAL MICROBIOLOGY REVIEWS
- Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas’ disease
- (2019) Yves Jackson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice
- (2019) Andreas K Lindner et al. LANCET INFECTIOUS DISEASES
- Assessing the effectiveness of curative benznidazole treatment in preventing chronic cardiac pathology in experimental models of Chagas disease
- (2018) Amanda Fortes Francisco et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trypanosoma cruzi biochemical changes and cell death induced by an organometallic platinum-based compound
- (2018) M. Florencia Mosquillo et al. Chemical Biology & Drug Design
- Current and Future Prospects of Nitro-compounds as Drugs for Trypanosomiasis and Leishmaniasis
- (2018) Alan H. Fairlamb et al. CURRENT MEDICINAL CHEMISTRY
- Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
- (2018) Faustino Torrico et al. LANCET INFECTIOUS DISEASES
- CYP51 as drug targets for fungi and protozoan parasites: past, present and future
- (2018) Galina I. Lepesheva et al. PARASITOLOGY
- Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery
- (2018) Lorna M. MacLean et al. PLoS Neglected Tropical Diseases
- Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure
- (2018) Fernando J Sánchez-Valdéz et al. eLife
- Effect of a new anti-T. cruzi metallic compound based on palladium
- (2018) M. Florencia Mosquillo et al. BIOMETALS
- The thiol-polyamine metabolism of Trypanosoma cruzi: molecular targets and drug repurposing strategies
- (2018) Alan Talevi et al. CURRENT MEDICINAL CHEMISTRY
- Imaging the development of chronic Chagas disease after oral transmission
- (2018) Michael D. Lewis et al. Scientific Reports
- Phenotypic screening approaches for Chagas disease drug discovery
- (2017) Eric Chatelain et al. Expert Opinion on Drug Discovery
- Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
- (2017) Stephen Brand et al. JOURNAL OF MEDICINAL CHEMISTRY
- Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers
- (2017) Carlos A. Morillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease
- (2017) Mario J. Olivera et al. PLoS One
- Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole
- (2017) Mônica C. Campos et al. Scientific Reports
- Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participation
- (2017) Paula Sartor et al. PLoS Neglected Tropical Diseases
- The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases
- (2017) William K. Redekop et al. PLoS Neglected Tropical Diseases
- 4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection
- (2017) Claudia Magalhaes Calvet et al. PLoS Neglected Tropical Diseases
- Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani
- (2017) Leah S. Torrie et al. ACS Infectious Diseases
- Current drug therapy and pharmaceutical challenges for Chagas disease
- (2016) José Bermudez et al. ACTA TROPICA
- Host and parasite genetics shape a link betweenTrypanosoma cruziinfection dynamics and chronic cardiomyopathy
- (2016) Michael D. Lewis et al. CELLULAR MICROBIOLOGY
- How Trypanosoma cruzi deals with oxidative stress: Antioxidant defence and DNA repair pathways
- (2016) Alice Machado-Silva et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
- (2016) Shilpi Khare et al. NATURE
- Benznidazole for Chronic Chagas’ Cardiomyopathy
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Putting Infection Dynamics at the Heart of Chagas Disease
- (2016) Michael D. Lewis et al. TRENDS IN PARASITOLOGY
- Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage
- (2016) Amanda Fortes Francisco et al. Scientific Reports
- Autoimmune Pathogenesis of Chagas Heart Disease
- (2015) Kevin M. Bonney et al. AMERICAN JOURNAL OF PATHOLOGY
- Impact of Benznidazole on Infection Course in Mice Experimentally Infected with Trypanosoma cruzi I, II, and IV
- (2015) Ana Paula Gruendling et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly SensitiveIn VivoImaging
- (2015) Amanda Fortes Francisco et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease
- (2015) Shilpi Khare et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cruzipain: An Update on its Potential as Chemotherapy Target against the Human Pathogen Trypanosoma cruzi
- (2015) M.H. Branquinha et al. CURRENT MEDICINAL CHEMISTRY
- Current and Future Chemotherapy for Chagas Disease
- (2015) Luís Gaspar et al. CURRENT MEDICINAL CHEMISTRY
- ABCG-like transporter of Trypanosoma cruzi involved in benznidazole resistance: Gene polymorphisms disclose inter-strain intragenic recombination in hybrid isolates
- (2015) Jaques Franco et al. INFECTION GENETICS AND EVOLUTION
- Dynamics of CYP51: implications for function and inhibitor design
- (2015) Xiaofeng Yu et al. JOURNAL OF MOLECULAR RECOGNITION
- Integrated control of Chagas disease for its elimination as public health problem - A Review
- (2015) Sergio Sosa-Estani et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy
- (2015) Carlos A. Morillo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease
- (2015) Tassiane Assíria Fontes Martins et al. PLoS One
- CD8+ T cells in Trypanosoma cruzi infection
- (2015) Rick L. Tarleton Seminars in Immunopathology
- New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
- (2015) Imanol Peña et al. Scientific Reports
- Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
- (2015) Jennifer Riley et al. PLoS Neglected Tropical Diseases
- Prevalence of Chagas Disease in Latin-American Migrants Living in Europe: A Systematic Review and Meta-analysis
- (2015) Ana Requena-Méndez et al. PLoS Neglected Tropical Diseases
- Immunity and immune modulation inTrypanosoma cruziinfection
- (2015) Fabíola Cardillo et al. Pathogens and Disease
- Bioluminescence imaging of chronicTrypanosoma cruziinfections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection
- (2014) Michael D. Lewis et al. CELLULAR MICROBIOLOGY
- Synthesis, Biological Evaluation, and Structure–Activity Relationships of Potent Noncovalent and Nonpeptidic Cruzain Inhibitors as Anti-Trypanosoma cruzi Agents
- (2014) Rafaela S. Ferreira et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chagas Disease Cardiomyopathy: Immunopathology and Genetics
- (2014) Edecio Cunha-Neto et al. MEDIATORS OF INFLAMMATION
- Benznidazole-resistance in Trypanosoma cruzi: Evidence that distinct mechanisms can act in concert
- (2014) Mônica C.O. Campos et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
- (2014) Israel Molina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
- (2014) Carolina B. Moraes et al. Scientific Reports
- Benznidazole prevents endothelial damage in an experimental model of Chagas disease
- (2013) Alfredo Molina-Berríos et al. ACTA TROPICA
- Unveiling Benznidazole's mechanism of action through overexpression of DNA repair proteins inTrypanosoma cruzi
- (2013) Matheus Andrade Rajão et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Global economic burden of Chagas disease: a computational simulation model
- (2013) Bruce Y Lee et al. LANCET INFECTIOUS DISEASES
- Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single Population
- (2012) Ana Maria Mejia et al. JOURNAL OF INFECTIOUS DISEASES
- Diagnosis and management of Chagas disease and cardiomyopathy
- (2012) Antonio L. Ribeiro et al. Nature Reviews Cardiology
- The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis
- (2012) S. Wyllie et al. Science Translational Medicine
- In vivosusceptibility to benznidazole ofTrypanosoma cruzistrains from the western Brazilian Amazon
- (2012) Ana P. M. Teston et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation
- (2011) Belinda S. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
- (2011) Shane R. Wilkinson et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites
- (2011) Belinda S. Hall et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Trypanosoma cruzi Protease Cruzain Mediates Immune Evasion
- (2011) Patricia S. Doyle et al. PLoS Pathogens
- Hydroxymethylnitrofurazone Is Active in a Murine Model of Chagas' Disease
- (2010) C. Davies et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chagas disease and stroke
- (2010) Francisco Javier Carod-Artal et al. LANCET NEUROLOGY
- The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 Å resolution
- (2010) Yihong Zhang et al. PROTEIN SCIENCE
- In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi
- (2010) Yen Ting Chen et al. PLoS Neglected Tropical Diseases
- Red-emitting luciferases for bioluminescence reporter and imaging applications
- (2009) Bruce R. Branchini et al. ANALYTICAL BIOCHEMISTRY
- Trypanocidal drugs: mechanisms, resistance and new targets
- (2009) Shane R. Wilkinson et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Ergosterol biosynthesis and drug development for Chagas disease
- (2009) Julio A Urbina MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Surgical treatment of Chagas megacolon. Critical analysis of outcome in operative methods
- (2008) Ricardo Luiz Santos Garcia et al. Acta Cirurgica Brasileira
- Insights into the redox biology of Trypanosoma cruzi: Trypanothione metabolism and oxidant detoxification
- (2008) Florencia Irigoín et al. FREE RADICAL BIOLOGY AND MEDICINE
- A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes
- (2008) Shane R. Wilkinson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search